VP
venBio Partners Portfolio holdings
AUM
$115M
This Quarter Return
+18.27%
1 Year Return
-33.99%
3 Year Return
+221.07%
5 Year Return
+224.54%
10 Year Return
–
AUM
$123M
AUM Growth
+$123M
(+224%)
Cap. Flow
+$71.4M
Cap. Flow
% of AUM
57.83%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
–
Reduced
1
Closed
–
Top Buys
| 1 |
Precision BioSciences
DTIL
|
$76.6M |
Top Sells
| 1 |
Apellis Pharmaceuticals
APLS
|
$5.15M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Precision BioSciences
DTIL
$57.8M
| $76.6M | 62% | +4,265,141 | New | +$76.6M |
|
|
2
Apellis Pharmaceuticals
APLS
$3.48B
| $29.8M | 24.1% | 1,526,122 -263,980 | -15% | -$5.15M |
|
3
VYNE Therapeutics
VYNE
$8.16M
| $11.5M | 9.29% | 1,461,552 | – | – |
|
|
VRNA
4
Verona Pharma
VRNA
$9.16B
| $5.69M | 4.61% | 875,000 | – | – |
|